Recently, I was delighted to attend the Pharma CI event in Newark, NJ which brought together competitive intelligence (CI) leaders from across the pharmaceutical industry to tackle the key challenges that face CI teams every day. In addition to catching up with familiar faces and meeting new people, I had the pleasure of taking the […]| Evaluate
Discover how a configurable treatment value model empowers pharmaceutical companies, healthcare professionals, and patients in emerging therapeutic markets—enhancing drug launch strategies, treatment access, and clinical decision-making with real-world data and cost transparency.| Evaluate
The obesity sector has witnessed robust GLP-1 deal making with pharma companies showing unprecedented appetite for strategic pharma deals.| Evaluate
“Nuclear winter” and “extinction event” were two of the less-than-positive terms used during last month’s BIO International convention to describe the biotech investment landscape..| Evaluate
Pharma industry trends 2025. Find 3 standout insights from Evaluate’s World Preview 2025 webinar, including the rise of integrated biotechs & China’s growing role. Watch now on demand.| Evaluate
Key considerations for creating more accurate patient-based product forecasts.| Evaluate
